Updated Jul 16, 2026
Benatti Luca is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $174K.
Luca Benatti is associated with Quince Therapeutics, Inc., a biopharmaceutical company focused on precision therapeutics for rare diseases. His specific role within the company is not detailed in the available information.
| Role | Insider |
|---|---|
| Notability | 40/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-12-29 | QNCX | Quince Therapeutics, Inc. | S — Open-market sale | 50.0K | $3.47 | $174K |
Luca Benatti is associated with Quince Therapeutics, Inc., a biopharmaceutical company focused on precision therapeutics for rare diseases. His specific role within the company is not detailed in the available information.…
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($174K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Benatti Luca profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.